Alacrita

Expertise-Based Consulting
Strategy | Analysis | Operations
follow us on twitter Newsletter signup »

  • About Alacrita
  • Our expertise
    • Industry Segment
    • Business Development
    • Intellectual Property
    • Product Development
    • Regulatory Affairs
  • Our services
  • Case Studies
  • News
  • Whitepapers
  • Our people
  • Advisory board
  • Contact us
a·lac·ri·ty [uh-lak-ri-tee] cheerful readiness, promptness, or willingness

News

news

whitepapers


RSS
  • Biotech In Israel - A Land Of Promise » 18 May 2012
  • Brian Howlett joins Alacrita's Advisory Board, reinforcing its Medtech capabilities » 21 March 2012
  • FDA Approvals Provide Reason for Cheer » 15 March 2012
  • Alacrita raises over $10,000 for Camfed International through Charity Auction of One-to-One Lunches with Senior Figures from the Pharma and VC Industries » 20 January 2012
  • Pharma Industry Myths » 6 January 2012
  • Charity Auction of Pharma Executive Lunches » 27 November 2011
  • New website design and content » 21 November 2011
  • Alacrita Establishes Powerful Regulatory Affairs Practice to Serve Life Science Companies and Investors » 3 October 2011
  • Europe's stellar decade of prostate cancer innovation » 6 September 2011
  • Alacrita Perspective: Are we all Biotech Now? » 20 June 2011
  • Martin Pue joins the Alacrita team » 12 May 2011
  • Alacrita Perspective: Biotechnology Opportunities in China » 31 March 2011
  • Alacrita sponsoring and attending BioTrinity 2011, Newbury, April 12-14 » 31 March 2011
  • Alacrita to attend BIO-Europe Spring, Milan » 2 March 2011
  • Alacrita establishes life sciences IP practice » 14 February 2011

Pages:1 2 Next »



©2011-12 Copyright Alacrita LLP Alacrita LLP. Registered in England & Wales, No. OC345738
Registered office: 2 Royal College Street, London NW1 0NH